Morphine - Revision history

Danbot: Switch SMW query from broadtable to table format for better layout with TOC

2026-03-20T21:56:03Z

Switch SMW query from broadtable to table format for better layout with TOC

2026-03-20T17:23:50Z

Fix SMW query: replace link=subject with mainlabel=- to fix broken subobject fragment links

2026-03-20T16:41:58Z

Add dynamic SMW Indications by Condition table (auto-populated from disease pages via MedicationDose template)

@@ Línea 81: / Línea 81: @@
 **Alters perception and response to pain
 **Produces CNS depression
 ==See Also==

2021-02-20T20:12:07Z

Adverse Reactions

← Revisión anterior		Revisión del 20:12 20 feb 2021
Línea 53:		Línea 53:
	==Adverse Reactions==		==Adverse Reactions==
	===Serious===		===Serious===
	*Circulatory depression, shock, cardiac arrest		*Circulatory depression, [[shock]], [[cardiac arrest]]
	*Bradycardia, hypotension		*[[Bradycardia]], hypotension
	*CNS depression, sedation		*[[CNS depression]], sedation
	*Apnea, respiratory arrest/depression		*Apnea, respiratory arrest/depression
	*Anaphylaxis, laryngospasm		*Anaphylaxis, laryngospasm
Línea 69:		Línea 69:
	*Hypoxia		*Hypoxia
	*Histamine release, urticaria		*Histamine release, urticaria
	*Afib, tachycardia, edema, chest pain		*[[Afib]], [[tachycardia]], edema, [[chest pain]]
	*Abdominal pain		*Abdominal pain

2021-02-20T20:11:01Z

General

← Revisión anterior		Revisión del 20:11 20 feb 2021
Línea 1:		Línea 1:
	==General==		==General==
	*Type: [[~~Opiods~~]]		*Type: [[Opioids]]
	*Dosage Forms: 5, 10, 15, 20, 30, 45, 50, 60, 75, 80, 90, 100, 120, 200, 0.5/ml, 1/ml, 2/ml, 4/ml. 5/ml, 8/ml, 10/ml, 15/ml, 25/ml, 50/ml,		*Dosage Forms: 5, 10, 15, 20, 30, 45, 50, 60, 75, 80, 90, 100, 120, 200, 0.5/ml, 1/ml, 2/ml, 4/ml. 5/ml, 8/ml, 10/ml, 15/ml, 25/ml, 50/ml,
	*Common Trade Names: Astramorph, AVINza, Duramorph, Infumorph, Kadian, MS contin		*Common Trade Names: Astramorph, AVINza, Duramorph, Infumorph, Kadian, MS contin

2020-11-26T22:43:31Z

Adult Dosing

← Revisión anterior		Revisión del 22:43 26 nov 2020
Línea 7:		Línea 7:
	*Acute pain (Moderate to severe):		*Acute pain (Moderate to severe):
	**Oral: 10-30mg q4hr PRN		**Oral: 10-30mg q4hr PRN
	**IM: 5-15mg ~~q4hr PRN~~		**IM: 5-15mg
	***Typically not recommended due to erratic absorption		***Typically not recommended due to erratic absorption
			***If utilized, no more than one IM dose should be given, due to the danger of "stacking" doses (may lead to respiratory compromise)
	**IV: 0.1 mg/kg bolus followed by 0.05 mg/kg q15-20 min until pain controlled		**IV: 0.1 mg/kg bolus followed by 0.05 mg/kg q15-20 min until pain controlled
	***Hold further doses for respiratory depression		***Hold further doses for respiratory depression

2020-11-21T05:30:03Z

Adult Dosing

← Revisión anterior		Revisión del 05:30 21 nov 2020
Línea 8:		Línea 8:
	**Oral: 10-30mg q4hr PRN		**Oral: 10-30mg q4hr PRN
	**IM: 5-15mg q4hr PRN		**IM: 5-15mg q4hr PRN
	**IV: 2.5-~~5mg q3hr PRN~~		***Typically not recommended due to erratic absorption
			**IV: 0.1 mg/kg bolus followed by 0.05 mg/kg q15-20 min until pain controlled
			***Hold further doses for respiratory depression
			***Dosed according to ideal body weight
	***AMI: 4-8mg q5-15min PRN		***AMI: 4-8mg q5-15min PRN
	***Critically ill: 2-4mg q1-2hr or 4-8mg q3-4hr PRN		***Critically ill: 2-4mg q1-2hr or 4-8mg q3-4hr PRN
Línea 22:		Línea 25:
	***Continuous microinfusion: 0.2-10mg over 24 hours (max ~20mg)		***Continuous microinfusion: 0.2-10mg over 24 hours (max ~20mg)
	**Rectal: 10-20mg q3-4hr		**Rectal: 10-20mg q3-4hr

	==Pediatric Dosing==		==Pediatric Dosing==
	*Children >6months and <50kg		*Children >6months and <50kg

2017-07-13T06:48:27Z

2017-07-07T08:43:11Z

Text replacement - "prn" to "PRN"

← Revisión anterior		Revisión del 08:43 7 jul 2017
Línea 6:		Línea 6:
	==Adult Dosing==		==Adult Dosing==
	*Acute pain (Moderate to severe):		*Acute pain (Moderate to severe):
	**Oral: 10-30mg q4hr ~~prn~~		**Oral: 10-30mg q4hr PRN
	**IM: 5-15mg q4hr ~~prn~~		**IM: 5-15mg q4hr PRN
	**IV: 2.5-5mg q3hr ~~prn~~		**IV: 2.5-5mg q3hr PRN
	***AMI: 4-8mg q5-15min ~~prn~~		***AMI: 4-8mg q5-15min PRN
	***Critically ill: 2-4mg q1-2hr or 4-8mg q3-4hr ~~prn~~		***Critically ill: 2-4mg q1-2hr or 4-8mg q3-4hr PRN
	**Continuous infusion IV, SC: 0.8-10mg/hr (up to 80mg/hr)		**Continuous infusion IV, SC: 0.8-10mg/hr (up to 80mg/hr)
	***Critically ill: 2-30mg/hr		***Critically ill: 2-30mg/hr
	***PCA 0.5-2.5mg q5-10min ~~prn~~		***PCA 0.5-2.5mg q5-10min PRN
	**Epidural (Preservative free)		**Epidural (Preservative free)
	***Single dose: 30-100mcg/kg		***Single dose: 30-100mcg/kg
Línea 25:		Línea 25:
	*Children >6months and <50kg		*Children >6months and <50kg
	*Acute pain (Moderate to severe)		*Acute pain (Moderate to severe)
	**Oral: 0.15-0.3mg/kg q3-4hr ~~prn~~		**Oral: 0.15-0.3mg/kg q3-4hr PRN
	**IM, SC: 0.1-0.2mg/kg		**IM, SC: 0.1-0.2mg/kg
	**IV: 0.05-0.3mg/kg q3-4hr ~~prn~~ (not to exceed 10mg/dose)		**IV: 0.05-0.3mg/kg q3-4hr PRN (not to exceed 10mg/dose)
	**Continuous infusion: 10-30mcg/kg/hr		**Continuous infusion: 10-30mcg/kg/hr
	**PCA 0.01-0.03mg/kg/dose and 0-0.03mg/kg/hr		**PCA 0.01-0.03mg/kg/dose and 0-0.03mg/kg/hr

2016-07-19T14:55:43Z

Text replacement - "0 mg" to "0mg"

← Revisión anterior		Revisión del 14:55 19 jul 2016
Línea 6:		Línea 6:
	==Adult Dosing==		==Adult Dosing==
	*Acute pain (Moderate to severe):		*Acute pain (Moderate to severe):
	**Oral: 10-~~30 mg~~ q4hr prn		**Oral: 10-30mg q4hr prn
	**IM: 5-15mg q4hr prn		**IM: 5-15mg q4hr prn
	**IV: 2.5-5mg q3hr prn		**IV: 2.5-5mg q3hr prn